RECANATINI, MAURIZIO
RECANATINI, MAURIZIO
DIPARTIMENTO DI FARMACIA E BIOTECNOLOGIE
3-(4-{[benzyl(methyl)amino]methyl}-phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation: A dual function lead for Alzheimer's disease therapy
2003 Piazzi L.; Rampa A.; Bisi A.; Gobbi S.; Belluti F.; Cavalli A.; Bartolini M.; Andrisano V.; Valenti P.; Recanatini M.
A comparative QSAR analysis of acetylcholinesterase inhibitors currently studied for the treatment of Alzheimer's disease
1997 Recanatini M.; Cavalli A.; Hansch C.
A comparative study on the application of hierarchical-agglomerative clustering approaches to organize outputs of reiterated docking runs.
2006 Bottegoni G.; Cavalli A.; Recanatini M.
A Computational Study of the Binding of Propidium to the Peripheral Anionic Site of Human Acetylcholinesterase
2004 CAVALLI A.; BOTTEGONI G.; RACO C.; DE VIVO M.; RECANATINI M.
A ligand-based virtual screening approach to identify small molecules as hERG channel activators
2015 Giacomini, E.; Buonfiglio, R.; Masetti, M.; Wang, Y.; Tseng, G.-N.; Roberti, M.; Recanatini, M.
A molecular dynamics study of reovirus attachment protein sigma1 reveals conformational changes in sigma1 structure
2004 CAVALLI A.; PROTA A.E.; STEHLE T.; DERMODY T.S.; RECANATINI M.; FOLKERS G.; SCAPOZZA L.
A natural-like synthetic small molecule impairs bcr-abl signaling cascades and induces megakaryocyte differentiation in erythroleukemia cells
2013 Turroni S.; Tolomeo M.; Mamone G.; Picariello G.; Giacomini E.; Brigidi P.; Roberti M.; Grimaudo S.; Pipitone R.M.; Di Cristina A.; Recanatini M.
A new class of nonsteroidal aromatase inhibitors: Design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17α-hydroxylase/C17,20-lyase
2001 Recanatini M.; Hartmann R.W.; Bisi A.; Cavalli A.; Belluti F.; Gobbi S.; Rampa A.; Valenti P.; Palzer M.; Palusczak A.
A small molecule targeting the multifactorial nature of Alzheimer's disease
2007 Cavalli A.; Bolognesi M. L.; Capsoni S.; Andrisano V.; Bartolini M.; Margotti E.; Cattaneo A.; Recanatini M.; Melchiorre C.
Acetylcholinesterase inhibitors as starting point towards improved Alzheimer’s disease therapeutics
2004 RECANATINI M.; VALENTI P.
Acetylcholinesterase inhibitors for potential use in Alzheimer's disease: Molecular modeling, synthesis and kinetic evaluation of 11H-indeno-[1,2-b]-quinolin-10-ylamine derivatives
2000 Rampa A.; Bisi A.; Belluti F.; Gobbi S.; Valenti P.; Andrisano V.; Cavrini V.; Cavalli A.; Recanatini M.
Acetylcholinesterase inhibitors in the context of therapeutic strategies to combat alzheimer's disease
2002 Recanatini M.; Cavalli A.
Acetylcholinesterase inhibitors: SAR and kinetic studies on ω-[N-methyl-N-(3-alkylcarbamoyloxyphenyl]methyl] aminoalkoxyaryl derivatives
2001 Rampa A.; Piazzi L.; Belluti F.; Gobbi S.; Bisi A.; Bartolini M.; Andrisano V.; Cavrini V.; Cavalli A.; Recanatini M.; Valenti P.
AClAP, Autonomous hierarchical agglomerative Cluster Analysis based protocol to partition conformational datasets
2006 Bottegoni G.; Rocchia W.; Recanatini M.; Cavalli A.
Affinity and selectivity at M2 and M3 muscarinic receptor subtypes of cyclic and open oxygenated analogues of 4-DAMP
1992 Tumiatti V.; Recanatini M.; Minarini A.; Melchiorre C.; Chiarini A.; Budriesi R.; Bolognesi M.L.
Alpha7 nicotinic acetylcholine receptor agonists: prediction of their binding affinity through a molecular mechanics Poisson-Boltzmann surface area approach
2008 Grazioso G.; Cavalli A.; De Amici M.; Recanatini M.; De Micheli C.
An automated docking protocol for HERG channel blockers.
2013 Di Martino G. P.; Masetti M.; Ceccarini L.; Cavalli A.; Recanatini M.
An Integrated Markov State Model and Path Metadynamics Approach to Characterize Drug Binding Processes
2019 Bernetti M.; Masetti M.; Recanatini M.; Amaro R.E.; Cavalli A.
An unsupervised computational pipeline identifies potential repurposable drugs to treat Huntington's disease and multiple sclerosis
2022 Menestrina, Luca; Recanatini, Maurizio
Antiproliferative agents that interfere with the cell cycle at the G(1)-->S transition: further development and characterization of a small library of stilbene-derived compounds
2008 Pizzirani D.; Roberti M.; Cavalli A.; Grimaudo S.; Di Cristina A.; Pipitone R.M.; Gebbia N.; Tolomeo M.; Recanatini M.